Jon Våbenø

Experimental Determination of Drug Diffusion Coefficients in Unstirred Aqueous Environments by Temporally Resolved Concentration Measurements

Massimiliano Pio di Cagno, Fabrizio Clarelli, Jon Våbenø et al. · Molecular Pharmaceutics · 2018 · 68 citations · Full text

Determination of the binding mode for the cyclopentapeptide<scp>CXCR</scp>4 antagonist<scp>FC</scp>131 using a dual approach of ligand modifications and receptor mutagenesis

Stefanie Thiele, Jignesh Mungalpara, Anne Steen et al. · British Journal of Pharmacology · 2014 · 46 citations · Full text

Diastereoselective Reduction of a Chiral <i>N</i>-Boc-Protected δ-Amino-α,β-unsaturated γ-Keto Ester Phe-Gly Dipeptidomimetic

Jon Våbenø, Magnus Brisander, Tore Lejon et al. · The Journal of Organic Chemistry · 2002 · 46 citations

Phe-Gly Dipeptidomimetics Designed for the Di-/Tripeptide Transporters PEPT1 and PEPT2:  Synthesis and Biological Investigations

Jon Våbenø, Tore Lejon, Carsten Uhd Nielsen et al. · Journal of Medicinal Chemistry · 2004 · 40 citations · Full text

Bioorganic Chemistry, Glycobiology, Organic Chemistry +19

Biased action of the CXCR4-targeting drug plerixafor is essential for its superior hematopoietic stem cell mobilization

Astrid Sissel Jørgensen, Viktorija Daugvilaite, Katia De Filippo et al. · Communications Biology · 2021 · 40 citations · Full text